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Background: Hypertension is an important and modifiable cardiovascular risk factor that remains under-detected
and under-treated, especially in the older individuals. Community-led interventions that integrate primary health
care and local resources are promising approaches to improve awareness and management of hypertension and
other cardiovascular risk factors. We aimed to evaluate the effect of a community-based Cardiovascular Health
Awareness Program (CHAP) on participants’ blood pressure.
Methods: This study followed a cohort of community residents that participated in CHAP across 22 mid-sized Ontario
communities over an 18-month period. The participants’ baseline risk factors, including blood pressure, and subsequent
measures of blood pressure were recorded. We employed a bivariate linear mixed-effect model to estimate the change
of systolic and diastolic blood pressure over time among the participants who attended more than two CHAP sessions.
Results: Of 13,596 participants, 2498 attended more than two CHAP sessions. For those repeated participants (attending
more than two sessions) initially identified with high blood pressure, the average reduction of systolic blood pressure
was from 142 to 123 mmHg over an 18-month period, a monthly rate ratio of 0.992 (95% CI: 0.991,0.994; p < 0.01).
Similarly, the average reduction of diastolic blood pressure was from 78 to 69 mmHg, a monthly rate ratio of 0.993 (95%
CI: 0.991,0.994; p < 0.01). The average blood pressure of the participants with normal baseline blood pressure remained
controlled and unchanged. We also found that older adult participants who lived alone, were diagnosed with
hypertension, reported healthier eating habits, and presented with a higher baseline systolic blood pressure had
significantly greater odds of attending more than one session.
Conclusions: CHAP was associated with a reduction in systolic and diastolic blood pressure for those participants who
attended more than one session. The magnitude of blood pressure reductions was significant clinically and statistically.Background
Cardiovascular disease (CVD), including heart failure, is-
chemic heart disease, and stroke, are the most common
causes of death in Canada [1]. Treatment of CVD ac-
counts for the largest proportion of Canadian health
care expenditures [1,2]. It is estimated that the majority
of CVD can be prevented through managing preventable
and modifiable risk factors. One readily preventable risk* Correspondence: ldolovic@mcmaster.ca
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reproduction in any medium, provided the orfactor of CVD is high blood pressure, also known as
hypertension. Hypertension is among the top leading
causes of death in the world [3]. In Canada, the preva-
lence of hypertension has remained relatively constant at
around 20% of adult population over the last 3 decades
(1985-2011). However, both the prevalence and inci-
dence of hypertension increases with age. Approximately
40% of Canadians have hypertension by the age of
55 years [4-6]. For those who do not have hypertension
by the age of 55 years, the residual lifetime risk of devel-
oping it is 90% [7].
Hypertension is generally asymptomatic. About 18% of
adults with hypertension are unaware of their condition
[8]. Another 18% of adults diagnosed with hypertensionThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Canadians with adequately controlled hypertension [8].
The main barriers to optimal diagnosis, treatment and
control include ‘white coat effect’ [9], ‘masked hyperten-
sion’ [10], co-morbidities [11,12], and non-adherence to
both pharmacological treatments and lifestyle recom-
mendations [13-17]. Both lifestyle and pharmacological
treatments have been shown to be effective at reducing
blood pressure (BP) and associated cardiovascular risk
factors. Improving BP control is one of the most cost-
effective health care interventions available [18]. A 10%
decrease in the prevalence of hypertension would save
more than $430 million per year in Canada [19]. More
importantly, it would have a major impact on reducing
cardiovascular morbidity and mortality.
Research suggests that community interventions that
have included BP monitoring in a non-clinical setting
and utilized community resources show promising results
on reducing and controlling BP among hypertensive pa-
tients [19-22]. Community resources such as volunteers,
pharmacists, health nurses, and local organizations are
underutilized to support disease prevention and primary
health care in Canada. Synergy created by connecting
family physicians, pharmacists, patients, peer volunteers
and local resources can lead to better health outcomes for
community residents [23].Cardiovascular health awareness program (CHAP)
The Cardiovascular Health Awareness Program (CHAP)
is a community-led approach that targets cardiovascular
awareness and prevention for the older adults by provid-
ing risk assessment, repeated measurement of BP, educa-
tion materials, lifestyle recommendations, and access to
community resources. The program integrates primary
care and local resources through the collaboration of
family physicians, pharmacists, local organizations, and
trained volunteer peer health educators [24]. Participa-
tion in CHAP is free and open to all residents of partici-
pating communities but individuals aged 65 years or
older are explicitly targeted. Potential participants are in-
vited by their family physicians to attend CHAP sessions
held in local pharmacies. Other invitation strategies in-
clude flyers, posters, and local media campaigns through
radio. The trained volunteer peer health educators, with
support from a community nurse and a local program
coordinator, lead CHAP sessions. In those sessions, peer
health educators assist participants to measure their
BP using an accurate automated device (BpTRU) and
complete a CVD risk profile. Based on the risk pro-
files, participants may be advised to attend another
session for re-assessment and follow up with their
family physician [24]. The action-oriented summaries
of up-to-date BP and CVD risk information are sentback to family physicians and pharmacists via an au-
tomated data system.
CHAP was developed and refined through several pilot
studies and community-wide demonstrations [24-27]. It
was most recently assessed in a randomized controlled
trial that randomly allocated 20 mid-sized communities
across Ontario, Canada to run CHAP compared with 19
control communities [22]. The result showed that CHAP
communities had a significant annual reduction of 9% in
cardiovascular hospital admissions in comparison with
non-CHAP communities (rate ratio 0.91, 95% confi-
dence interval 0.86 to 0.97; p = 0.002). After these prom-
ising results, CHAP continued to be implemented in 22
mid-sized communities across Ontario. The on-going
goal is to develop CHAP as a sustainable community-
owned program, with the aim of localizing community
resources to ultimately achieve improved long-term
health outcomes. CHAP is continuously evaluated by
routinely collected data from the 22 communities. This
is a unique data set from a real-world program that was
able to follow participants for a number of months. The
on-going implementation and evaluation of CHAP is an
important step forward for community-led cardiovascu-
lar prevention programs which, up till now, have pro-
duced largely disappointing effects on clinical outcomes
[11-13,28,29]. Today, 9 communities in Ontario have
successfully adopted CHAP as their regular community
program. A CHAP implementation guide targeting com-
munity end-users has been built to provide a ‘road map’
for new communities who are interested in implement-
ing CHAP (www.chapprogram.ca). Part of current work
on CHAP focuses on understanding the longitudinal effect
of CHAP on reducing BP among hypertensive patients
and the characteristics associated with participants’ par-
ticipation in the program. The analyses are mainly to in-
form further operations of CHAP about an array of
features of the program that arises in real-world imple-
mentation of the program.
In this paper, our objectives are to estimate the
changes of participants’ BP over subsequent visits and
examine what factors were associated with individuals’
continuous participation in CHAP.Methods
Ethics statement
The participation in CHAP sessions was voluntary and
did not require participants’ consent. However, blood
pressure readings and other information on cardiovascu-
lar risk factors were collected and sent back to their
family physician and regular pharmacist with partici-
pants’ written consent. The study and the consent pro-
cedure were approved by the research ethics boards at
Bruyère Continuing Care in Ottawa, Sunnybrook Health
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Study design
This longitudinal cohort study followed the participants
who attended CHAP sessions between May 2008 and
April 2010. These CHAP sessions were delivered weekly
in 22 communities after the completion of the RCT.
Although those sessions were run independently of the
main study, they were organized in the same way. Phys-
ician referral and local advertisements were the primary
means of inviting participants. In those CHAP sessions,
trained volunteer peer health educators assisted partici-
pants to take BP measurements with the BpTRU device
and recorded self-reported CVD risk factors on the stan-
dardized risk profile form. An on-site community nurse
was available to assess participants who had abnormal
BP and trained volunteer peer health educators referred
eligible participants to community pharmacists for a
medication assessment. The medication assessment was
a one-to-one meeting to ensure the safe and appropriate
use of all types of medication. The CVD risk factors col-
lected at baseline included the participants’ age, gender,
body mass index (BMI), systolic blood pressure (SBP),
diastolic blood pressure (DBP), history on transient is-
chemic attack (TIA), stroke, heart attack, high choles-
terol and high BP, smoking status, drinking habits,
eating habits (the consumption of high fat foods, vegeta-
bles, fruit and salt), stress level, physical exercises, and
whether they lived alone or not. A detailed protocol of
CHAP intervention can be found here [30]. The clinical
outcomes of interest were SBP and DBP. Participants’
SBP and DBP were recorded during repeated CHAP ses-
sions using standardized protocols, assistance from peer
health educator volunteers, and validated automated BP
devices. In keeping with the BpTRU protocol, during the
first visit and subsequent visits, the BpTRU automated
blood pressure measuring device independently assessed
the blood pressure with volunteer peer health educators
assisting with the cuff size, if required, and assisting with
recording the blood pressure taken on the data collec-
tion form. The first reading was automatically discarded
and the volunteer recorded the mean value of the five
subsequent measurements produced by the BpTRU on
the participant’s form. In CHAP, the BpTRU is set to
have a one-minute interval between readings. A typical
period of time required at a session was 20 minutes.
There are two considerations for the analysis of the re-
peated BP measurements. First, the number of total BP
measurements was generally different among partici-
pants. Second, the time interval between consecutive
measurements also varied. This was due to CHAP being
a volunteer self-directed program that allowed participants
to attend as many sessions as they wished. The number ofparticipants also decreased over time (Figure 1). These un-
equally spaced BP observations created challenges in the
analysis because the time interval between consecutive
measures is not the same for all participants.
Statistical analysis
Participants were divided into three groups for the ana-
lysis: participants who attended only one session, two
sessions, or more than two sessions (Figure 2). Mean
(standard deviation) and number of count (percentage)
were calculated for the continuous variables and cat-
egorical variables, respectively. The literature on longitu-
dinal analysis suggests a minimum of at least three
consecutive measures to model change through time
[31]. Thus, for estimating the longitudinal effect of
CHAP on reducing BP, only participants with more than
two visits were included in the analysis.
A bivariate linear mixed-effect model [32-34] was used
to fit SBP and DBP simultaneously by taking into ac-
count the correlation between both measures. The time
of measurement was used as a continuous variable. That
way, we could relate the SBP and DBP measurements to
the individual time of observation to address the prob-
lem of unequally spacing between visits [35-38]. A con-
tinuous autoregressive (CAR) structure was specified for
modeling the within-subject variance of the BP measure-
ments. The CAR structure treated time between sessions
as a continuous variable and allowed time-dependent
correlation between measurements, e.g. the correlation
between BP measurements got smaller when they were
further apart. The details of the model are provided in
the Additional file 1.
A logarithm transformation was applied to the out-
comes to adjust for non-linear reduction over time. The
SBP and DBP dropped more quickly at earlier sessions
and then the reduction became smaller and smaller. In
the model, we included a baseline binary variable to in-
dicate whether the participants initially had high BP or
not. According to the Canadian hypertension education
program recommendations [39], the cut-off defining
high SBP/DBP is ≥ 140/90 mmHg for individuals without
diabetes and ≥ 130/80 for individuals with diabetes. The
participants were classified in the high BP group at base-
line if either SBP or DBP was above the threshold. An
interaction term between the BP level indicator and the
time variable was also included to allow the rate of BP
change to vary between participants of different levels of
initial BP.
A second analysis was conducted to examine the fac-
tors that were associated with participation in CHAP.
Two logistic regression models were fitted on all partici-
pants for the odds of ever returning for another session
and the odds for a new participant to be advised for the
second session, respectively. The overall rate of missing
Figure 1 Distribution of the number of participants over time (more than two visits). This figure shows the distribution of the number of CHAP
participants who attended more than two sessions by month. The number of participants generally decreases over time. There are more participants
in some months than in previous months because CHAP being a volunteer self-directed program allows participants to attend any session.
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sumed any missing observation to be missing at random
(MAR) and used the multiple imputation (MI) technique
to generate those missing values by baseline factors. The
Monte Carlo Markov Chain (MCMC) method was usedFigure 2 Flowchart of the study participants. This flowchart divides the
sessions or more than two sessions. It shows the number of participants foto simulate the sampling distribution for 10 imputation
draws. We reported the estimate of BP change in rate ra-
tio (RR), corresponding 95% confidence interval (CI) and
p value. We chose the alpha to be 5%. All statistical ana-
lyses were performed in SAS 9.2 (SAS Institute, Cary NC).number participants by the number of sessions: one session, two
r baseline comparison and the longitudinal analysis.
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CHAP sessions processed 13,596 participants between
May 2008 and April 2010: 70% (9,531 of 13,596) attended
only one session; 12% (1,567 of 13,596) attended two ses-
sions; and 18% (2,498 of 13,596) attended more than two
sessions. The baseline variables are summarized in Tables 1
and 2. The average SBP, DBP, and BMI scores on all par-
ticipants were 128 mmHg, 74 mmHg, and 28 kg/m2, re-
spectively and were similar across the subgroups. The
average age was 67 years old and was higher among the
participants who attended more than one session. Overall,
8.9% (1,101 of 12,304) participants reported a previous
heart attack; 41.1% (5,048 of 12,288) reported high choles-
terol; 16.0% (1,968 of 12,299) reported diabetes; and 54.0%
(6,636 of 12,280) reported hypertension. The participants
who attended multiple sessions reported more cardiovas-
cular disease histories. The participants who attended
more than one session reported a healthier lifestyle than
those who attended only one session, e.g. less smoking,
alcohol, high fat food, salt and stress, and more fruit,Table 1 Summary of baseline categorical risk factors
Risk factors All participants
(n = 13596)
Count Percentage
Gender Male 4987 36.7%
Age ≥ 65 years old 8495 62.5%
BP level High 3975 29.3%
Previous TIA? Yes 893 7.3%
Previous stroke? Yes 370 3.0%
Previous heart attack? Yes 1101 8.9%
High cholesterol? Yes 5048 41.1%
Diabetes? Yes 1968 16.0%
Hypertension? Yes 6636 54.0%
Currently smoking? Yes 1424 11.6%
How many times eating high fat
food weekly?
3 or more 1247 10.1%
1-2 times 7099 57.7%
Zero 3953 32.1%
2+ alcoholic drinks daily? Yes 1003 8.2%
5+ servings of fruit and vegetable? Yes 7482 61.2%
Adding salt to food? Often 1693 13.8%
Sometimes 3059 25.0%
Rarely 7476 61.1%
Feeling stressed? Often 2033 16.6%
Sometimes 4553 37.2%
Rarely 5645 46.2%
Daily exercise? Yes 9563 77.7%
Live alone? Yes 3615 29.4%
BP = blood pressure; TIA = transient ischemic attack.vegetables and physical activity. Also, the participants who
lived by themselves were more likely to attend more
sessions.
In Table 3, we summarize the results for estimating
the BP change over repeated visits. The rate ratio (RR)
estimate of BP change was interpreted as the percentage
of BP change each month. For the participants initially
identified with high BP, the RR of SBP and DBP was
0.9921 (95% CI: 0.9905,0.9937; p < 0.01) and 0.9929 (95%
CI: 0.9914,0.9944; p < 0.01), respectively. These results
showed that on average the SBP and DBP dropped 0.79%
and 0.71%, respectively every month in CHAP. In con-
trast, the RR of SBP and DBP for the participants without
high BP was 0.9999 (95% CI: 0.9993,1.0004; p = 0.69) and
0.9996 (95% CI: 0.9990,1.0001; p = 0.11), respectively.
That represented an average drop of 0.01% and 0.04% on
SBP and DBP, respectively every month. In summary, the
average SBP/DBP for the high BP group was reduced from
142/78 mmHg to 123/69 mmHg over an 18-month








visits (n = 2498)
Count Percentage Count Percentage Count Percentage
3525 37.2% 580 37.0% 865 34.6%
5432 57.0% 1119 71.5% 1944 77.8%
2744 28.8% 429 27.4% 802 32.2%
581 6.7% 106 7.6% 198 8.9%
239 2.8% 42 3.0% 85 3.8%
750 8.7% 139 10.0% 208 9.4%
3433 39.8% 608 43.6% 976 44.2%
1349 15.6% 216 15.5% 397 18.0%
4377 50.8% 819 58.8% 1408 63.7%
1115 12.9% 132 9.5% 172 7.8%
922 10.7% 124 8.9% 196 8.8%
4996 57.9% 819 58.8% 1252 56.5%
2717 31.5% 451 32.4% 768 34.7%
734 8.5% 110 7.9% 157 7.1%
5126 59.8% 855 61.7% 1463 66.5%
1278 14.9% 165 11.9% 237 10.7%
2140 24.9% 351 25.3% 554 25.1%
5160 60.2% 874 62.9% 1415 64.1%
1513 17.6% 217 15.7% 292 13.2%
3210 37.4% 503 36.3% 821 37.3%
3865 45.0% 665 48.0% 1091 49.5%
6701 77.5% 1087 77.8% 1732 78.1%
2328 27.0% 456 32.6% 1398 36.8%
Table 2 Summary of baseline continuous risk factors
Risk factors All participants (n = 13596) Participants with only 1 visit
(n = 9531)
Participants with 2 visits
(n = 1567)
Participants with more than 2 visits
(n = 2498)
Mean SD Mean SD Mean SD Mean SD
SBP (mmHg) 128.0 19.1 127.3 19.1 128.2 18.6 129.9 19.0
DBP (mmHg) 74.3 11.2 74.7 11.1 72.9 11.0 73.1 11.0
Age (year) 67.1 13.5 65.4 14.1 70.1 12.0 71.7 10.5
BMI (kg/m2) 27.9 5.4 28.0 5.4 27.7 5.4 27.7 5.3
SD = standard deviation; SBP = systolic blood pressure; DBP = diastolic blood pressure; BMI = body mass index.
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line, the ones who reported diabetes on average had 2.5
and 3.3 mmHg more reduction in SBP and DBP, respect-
ively, than those who did not. In contrast, for the partici-
pants who did not show high BP at baseline, the ones who
reported diabetes on average had 2.9 and 3.0 mmHg more
reduction in SBP and DBP, respectively, than those who
did not. Figures 3 and 4 illustrate the trend of BP reduc-
tion over time. We have examined the multi-collinearity
among the baseline risk factors by calculating their vari-
ance inflation factor (VIF) and did not find any strong
multi-collinearity, i.e. VIF < 10.
The 22 mid-sized communities in this study are simi-
lar in their demographic profile, e.g. population compos-
ition, income, and residents’ education level. The
distribution of BP for CHAP participants in each com-
munity is also similar but the number of total population
varies. To explore the community effect on the BP
change, we fitted a mixed-effect model by incorporating
an additional community factor in the hierarchical struc-
ture (i.e. visit, participant and community levels). The
estimated rates of BP change were similar to those ob-
tained previously. However, the 3-level model resulted in
a non-positive Hessian matrix, suggesting unstable esti-
mates and potential over-specification of the model [40].
Thus, we report the mixed-effect model without the
community factor since it provides stable estimates with
a simpler covariance structure.Table 3 Summary of results from the bivariate linear mixed-e
Systolic blood pressure
RR* 95% CI p va
High blood pressure at baseline
Baseline 141.61 (138.56 144.74) <0.
Rate ratio 0.9921 (0.9905 0.9937) <0.
Not high blood pressure at baseline
Baseline 120.44 (118.79 122.12) <0.
Rate ratio 0.9999 (0.9993 1.0004) 0.6
RR = rate ratio; CI = confidence interval.
Rate ratio was expressed as the change of current blood pressure in 1 month.
*The rate ratio was adjusted for all baseline risk factors.In Table 4, we summarize the results from the logistics
regression analyses examining the factors associated with
participation in CHAP. The odds of attending multiple
sessions were increased by 3% (OR 1.03, 95% CI: 1.03-
1.04; p < 0.01) for every year increase in age. The partici-
pants who were diagnosed with hypertension, ate more
than five servings of fruit and vegetables daily, rarely
added salt to food, and lived alone had 30% (OR 1.30,
95% CI: 1.19-1.42; p = 0.01), 14% (OR 1.14, 95% CI: 1.04-
1.24; p = 0.01), 18% (OR 1.18, 95% CI: 1.03-1.34; p =
0.02) and 17% (OR 1.17, 95% CI: 1.06-1.28; p < 0.01)
higher odds of attending more than one session than
those who did not, respectively. Also, the new participants
who often felt stressed were associated with 19% higher
odds of being advised to attend the second session.
Discussion
In this study, BP of CHAP participants initially identified
with high BP significantly dropped over time. An average
reduction of 20/10 mmHg in SBP/DBP occurred over
18 months. Such a reduction in BP greatly lowers the
risk of developing cardiovascular disease. A decrease of
SBP/DBP by 10/5 mmHg reduces the risk of developing
heart failure by about 50%, stroke by 38%, heart attack
by 15%, and death by 10% [41]. At the same time, the
participants without high BP at baseline were also well
controlled in terms of their follow-up BP. These findings
support our hypothesis that the use of communityffect model
Diastolic blood pressure
lue RR* 95% CI p value
01 78.13 (75.99 80.32) <0.01
01 0.9929 (0.9914 0.9944) <0.01
01 69.93 (68.67 71.21) <0.01
9 0.9996 (0.9990 1.0001) 0.11
Figure 3 Reduction of systolic blood pressure over time. This figure shows the reduction of systolic blood pressure for the participants who
attended more than two sessions. The reduction is presented separately for those who presented with high blood pressure at baseline (without
diabetes: systolic blood pressure≥ 140 or diastolic blood pressure≥ 90; with diabetes: systolic blood pressure≥ 130 or diastolic blood pressure≥ 80)
and for those who did not.
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received at the family physician’s office overcome trad-
itional barriers associated with measuring, treating, and
controlling BP at a doctor’s office [23,24].
When compared with the participants who attended
only one session, we found that the participants who
attended multiple sessions generally presented with higher
baseline cardiovascular risk and a healthier lifestyle. Par-
ticipants who lived by themselves were more likely to
come back for more CHAP sessions. From the logistic
regression analysis, we found that older adult partici-
pants who lived alone, were diagnosed with hypertension
previously, had healthier eating habits, and presented
with higher baseline SBP had a greater likelihood of attend-
ing more than one CHAP session. In addition, for thoseFigure 4 Reduction of diastolic blood pressure over time. This figure s
who attended more than two sessions. The reduction is presented separat
(without diabetes: systolic blood pressure≥ 140 or diastolic blood pressure
pressure≥ 80) and for those who did not.participants who often felt stressed, they were much likely
to be recommended to come back for re-assessment.
Our study was limited by a number of factors. First,
risk factors were only recorded at baseline and, apart
from BP, were self-reported. This prevented us from ac-
counting for the change of risk factors over time. Sec-
ond, by the pragmatic nature of the study, we cannot
know which specific components of CHAP were work-
ing to reduce BP for the participants. For example, the
BP reduction could be a result of an improved detection
and treatment of hypertension, improved adherence to
lifestyle changes or pharmacological treatments, more fre-
quent follow-ups by family physicians initiated by CHAP
for cardiovascular disease prevention, or greater efforts
by integrating local resources to promote cardiovascularhows the reduction of diastolic blood pressure for the participants
ely for those who presented with high blood pressure at baseline
≥ 90; with diabetes: systolic blood pressure≥ 130 or diastolic blood
Table 4 The summary of results from the logistic regression models
Being advised to attend the second session Attending multiple sessions
Baseline factors OR 95% CI p value OR 95% CI p value
Age 1.01 1.00 1.01 0.04 1.03 1.03 1.04 <0.01
BMI 1.00 0.99 1.02 0.44 1.00 1.00 1.01 0.78
SBP 1.02 1.01 1.02 <0.01 1.00 1.00 1.00 0.02
DBP 1.01 1.00 1.01 0.04 1.00 1.00 1.00 0.11
Gender
Male1 1.11 1.00 1.23 0.06 1.00 0.91 1.11 0.98
Previous TIA?
Yes2 0.96 0.78 1.20 0.74 0.94 0.79 1.11 0.91
Previous stroke?
Yes2 1.01 0.72 1.41 0.97 1.07 0.83 1.38 0.55
Previous heart attack?
Yes2 1.12 0.95 1.33 0.17 0.89 0.76 1.03 0.27
High cholesterol?
Yes2 1.05 0.94 1.17 0.36 1.01 0.93 1.10 0.31
Diabetes?
Yes2 1.11 0.95 1.29 0.18 0.96 0.85 1.08 0.46
Hypertension?
Yes2 1.19 0.98 1.44 0.07 1.30 1.19 1.42 0.01
Currently smoking?
Yes2 1.01 0.85 1.20 0.89 0.87 0.75 1.01 0.06
How many times eating high fat food in a week?
Zero3 0.93 0.76 1.14 0.48 0.90 0.77 1.06 0.22
1-2 times3 0.95 0.79 1.14 0.58 0.97 0.83 1.12 0.63
Two or more alcoholic drinks a day?
Yes2 0.92 0.77 1.09 0.34 0.94 0.80 1.10 0.26
At least five servings of fruits and vegetables daily?
Yes2 1.10 0.98 1.22 0.10 1.14 1.04 1.24 0.01
Adding salt to food?
Rarely4 1.06 0.92 1.23 0.43 1.18 1.03 1.34 0.02
Sometimes4 1.08 0.93 1.27 0.31 1.16 1.00 1.34 0.05
Feeling stressed?
Rarely4 0.84 0.73 0.98 0.02 1.04 0.92 1.19 0.98
Sometimes4 0.80 0.69 0.92 <0.01 1.06 0.93 1.21 0.79
Daily exercise for 30 to 60 minutes most days
Yes2 0.97 0.86 1.10 0.64 1.05 0.94 1.16 0.19
Live alone?
Yes2 1.16 1.04 1.29 0.01 1.17 1.06 1.28 <0.01
BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure; TIA = transient ischemic attack; OR = odds ratio; CI = confidence interval.
1Compared with female as reference category.
2Compared with ‘no’ as reference category.
3Compared with ‘3 or more’ as reference category.
4Compared with ‘often’ as reference category.
Significant p values (≤ 0.05) were bolded.
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was effective in reducing BP in the elderly residing in mid-
sized Ontario communities. These findings may not be
generalizable to larger communities or urban centers
where healthcare is delivered differently [22]. Fourth,
CHAP was explicitly designed to target the older adults
who are at least 65 years old. Thus, our findings may not
hold for younger people. Fifth, the participation in CHAP
was on a self-directed basis and the attrition was signifi-
cant. The majority of participants attended no more than
two sessions and were excluded from the longitudinal ana-
lysis of BP reduction over time. We were not able to fol-
low those participants for their cardiovascular condition
and lifestyle change at various months of the study
although the baseline comparison showed that the partici-
pants with fewer visits had lower cardiovascular risk and a
less healthy lifestyle. Finally, the estimates of BP reduc-
tions were derived for the population average rather than
individual participants. Limited by the design, we did not
protect the study from regression to the mean (RTM) bias
by randomly allocating the CHAP intervention to the par-
ticipants who had high BP at baseline and those who did
not. However, we tried to reduce the RTM bias by record-
ing the average BP in each measurement. We also ac-
counted for the participants’ baseline BP when estimating
the BP change. Both approaches were suggested by
Barnett et al. to deal with MTR bias [42]. Using the stand-
ard formula [42], we calculated the effect of RTM in our
sample to be approximately 2.0 and 0.6 mmHg for SBP
and DBP, respectively. Both numbers imply a weak effect
of RTM in the participants’ mean SBP and DBP.
Despite the limitations, this study has several important
strengths. The CHAP intervention is evaluated by large-
scale population-based data that enables longer follow-up
and larger sample size. Data are rarely available for evalu-
ation of a real-world program at this scale. The continu-
ous and accurate monitoring of blood pressure in a
familiar environment allows for a better level of diagnosis,
treatment, and control of hypertension. Among the CHAP
participants initially identified with elevated BP, 33% of
them did not report hypertension, suggesting that these
individuals might not be aware of their condition. More-
over, 11% of the participants diagnosed with hypertension
previously were not receiving antihypertensive medication.
When we explored the group of participants who showed
high BP at baseline, we did not find any significant differ-
ence in the BP change between the ones who reported
hypertension and those who did not. On average, the ones
who did not report hypertension had only 0.11% (p = 0.39)
and 0.17% (p = 0.15) more reduction per month in SBP
and DBP, respectively, than those who did. Traditional
system barriers associated with a clinical setting are over-
come by the use of community pharmacies and volunteer
peer health educators who are closely related to theirpeers. A system such as this also helps to enhance partici-
pant adherence to recommended lifestyle changes and
pharmacologic treatments.
Some well-known community-wide interventions for
CVD [11-13,28,29] have failed to detect significant
changes in CVD risk factors or have shown only modest
improvements in BP. Those studies were largely limited
by small size, short duration, narrow penetration of the
intervention, and a focus shifted from awareness and
prevention [43,44]. In addition to overcoming those limi-
tations, CHAP adopts a community-led, collaborative
approach to primary health care and cardiovascular health
awareness. It removes traditional barriers to monitoring
and management of blood pressure [45]. Unlike other
community BP monitoring initiatives, CHAP ensures that
accurate and up-to-date information is forwarded to
participants’ family physician and pharmacist [46]. The A-
CHAMP in Alberta [19], a community BP program built
on the CHAP model, also showed a significant BP reduc-
tion after a 6-month follow-up.
Hypertension among the modifiable risk factors of
CVD represents a major public health issue and its sub-
optimal detection and treatment is a major burden on
health care expenditures and significant CVD morbidity
and mortality for those who are not adequately con-
trolled [22]. CHAP offers a feasible, community-based,
and affordable means to improve the BP management.
Considering that 36% of Canadians aged 65 to 74 are
uncontrolled [8], CHAP appears to present a significant
step forward in the prevention of cardiovascular disease
through monitoring individuals’ BP.
Conclusions
Hypertension is highly preventable and manageable through
lifestyle changes and pharmacological treatments. Our
study showed that the CHAP participants initially identified
with high BP experienced a significant reduction of BP dur-
ing repetitive visits. Participants who presented with higher
risks of developing cardiovascular diseases were more likely
to attend multiple sessions. CHAP integrates community
resources to promote cardiovascular health awareness and
prevention among older adults to improve the diagnosis,
treatment, and control of blood pressure, thus decreasing
the risk of developing cardiovascular disease.
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